KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?

dc.contributor.author	Ozguroglu, M.
dc.contributor.author	Erdamar, S.
dc.contributor.author	Selcukbiricik, F.
dc.contributor.author	Buyukunal, E.
dc.contributor.author	Ozturk, M. A.
dc.contributor.author	Serdengecti, S.
dc.contributor.author	Demir, G.
dc.contributor.author	Mandel, N. M.
dc.contributor.author	Tural, D.
dc.contributor.author	Yildiz, O.
dc.date.accessioned	2021-03-06T10:04:20Z
dc.date.available	2021-03-06T10:04:20Z
dc.identifier.citation	Selcukbiricik F., Yildiz O., Tural D., Ozturk M. A. , Demir G., Ozguroglu M., Erdamar S., Buyukunal E., Mandel N. M. , Serdengecti S., "KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?", European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47
dc.identifier.other	vv_1032021
dc.identifier.other	av_e897c90a-de3e-423f-b193-0fc1603c44a0
dc.identifier.uri	http://hdl.handle.net/20.500.12627/152855
dc.identifier.uri	https://doi.org/10.1016/s0959-8049(11)71665-3
dc.language.iso	eng
dc.subject	Onkoloji
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?
dc.type	Bildiri
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	47
dc.contributor.firstauthorID	138577

Files in this item

Files	Size	Format	View
There are no files associated with this item.